NOVAVAX INC — Director's Dealing 2015

Aug 17, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2015-08-13

Reporting Person: EVANS GARY C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-08-13	Common Stock	M	15000	$0.56	Acquired	336979	Direct
2015-08-13	Common Stock	M	30000	$1.28	Acquired	366979	Direct
2015-08-13	Common Stock	S	6002	$13.5618	Disposed	360977	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-08-13	Stock Option (Right to buy)	$0.056	M	15000	Disposed	2019-03-05	Common Stock (15000)	Direct
2015-08-13	Stock Option (Right to buy)	$1.28	M	30000	Disposed	2022-03-01	Common Stock (30000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	8000	Indirect

Footnotes

F1: The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.5301 to $13.585, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.

F2: Includes 4,000 shares owned of record by Gary Evans Custodian for Dustin Evans UTMA/TX and 4,000 shares owned of record by Gary Evans Custodian for Casey Evans UTMA/TX.

F3: The 15,000 shares exercised on 08/13/2015 pursuant to this stock option vested on 09/05/2009.

F4: The 30,000 shares exercised on 08/13/2015 pursuant to this stock option vested on 09/01/2012.